Danaher, Moderna, and ImmunityBio are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that research, develop, and...
MarketBeat·18h ago
More News
MRNA Stock Gains After CHMP Endorses COVID-19-Influenza Combo Shot
Moderna jumps 4% after EU panel backs mCombriax, its COVID-19-flu combo shot, with phase III data showing stronger immune response vs standalone vaccines.
Zacks·1d ago
Promising Biotech Stocks To Research - March 1st
Danaher, Vertex Pharmaceuticals, Moderna, argenex, United Therapeutics, ImmunityBio, and Medpace are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech...
MarketBeat·2d ago
Biotech Stocks To Keep An Eye On - February 28th
Danaher, Vertex Pharmaceuticals, and Moderna are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that research, develop...
MarketBeat·3d ago
This Is What Whales Are Betting On Moderna
read more...
Benzinga·4d ago
Promising Biotech Stocks To Consider - February 27th
Danaher, Vertex Pharmaceuticals, argenex, ImmunityBio, and Moderna are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly...
MarketBeat·4d ago
Top Biotech Stocks To Follow Now - February 26th
argenex, ImmunityBio, Danaher, Novavax, Moderna, Vertex Pharmaceuticals, and Vir Biotechnology are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech...
MarketBeat·5d ago
Insider Selling: Moderna (NASDAQ:MRNA) President Sells 160,009 Shares of Stock
Moderna, Inc. (NASDAQ:MRNA - Get Free Report) President Stephen Hoge sold 160,009 shares of the firm's stock in a transaction on Monday, February 23rd. The stock was sold at an average price of...
MarketBeat·5d ago
Stephen Hoge Sells 160,009 Shares of Moderna (NASDAQ:MRNA) Stock
Moderna, Inc. (NASDAQ:MRNA - Get Free Report) President Stephen Hoge sold 160,009 shares of the firm's stock in a transaction on Monday, February 23rd. The stock was sold at an average price of...
MarketBeat·6d ago
Moderna's Ups and Downs: Here's What You Need to Know Before Investing.
Key PointsModerna has faced good and bad times in recent years...